Collaboration with APIS Assay Technologies to assess the suitability of TROLL-2 and TROLL-3 as predictive biomarkers of cancer progression and their role as markers of chemotherapy response
|
|
Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation
|
|
TAp63-Regulated miRNAs Suppress Cutaneous Squamous Cell Carcinoma through Inhibition of a Network of Cell-Cycle Genes
|
|
∆Np63/DGCR8- Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.
|
|
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
|
|
TAp63 is the master transcriptional regulator of lipid and glucose metabolism
|
|
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
|
|
DeltaNp63 transcriptionally regulates brachyury, a gene with diverse roles in limb development, tumorigenesis and metastasis
|
|
TAp63 prevents premature aging by promoting adult stem cell maintenance
|
|
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
|
|